| |
| |
|
| Insider
Information: |
Malik Fady Ibraham |
| Relationship: |
EVP Research & Develop... |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
135,004 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$7,280,766 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
135,004 |
|
|
| Total
Value |
$7,280,766 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
7
|
|
Stock
price went up :
|
0
|
5
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
2.5
|
| Percentage
Gain/Loss : |
0.0%
|
 322.1%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Cytokinetics Inc |
CYTK |
EVP Research & Develop... |
2024-06-11 |
135,004 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• • – |
2024-01-04 |
4 |
AS |
$86.98 |
$1,363,712 |
D/D |
(15,678) |
146,973 |
0 |
% |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• • – |
2024-02-06 |
4 |
AS |
$79.28 |
$2,585,497 |
D/D |
(32,605) |
142,973 |
0 |
% |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• • – |
2024-04-09 |
4 |
S |
$74.31 |
$2,422,918 |
D/D |
(32,605) |
138,567 |
0 |
% |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• • – |
2024-03-04 |
4 |
D |
$67.68 |
$651,758 |
D/D |
(9,630) |
133,343 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• • – |
2024-03-05 |
4 |
AS |
$67.53 |
$2,202,606 |
D/D |
(32,604) |
138,973 |
0 |
% |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• • – |
2024-03-06 |
4 |
D |
$66.88 |
$542,330 |
D/D |
(8,109) |
121,234 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• • – |
2024-05-07 |
4 |
AS |
$65.11 |
$1,012,265 |
D/D |
(15,547) |
137,056 |
0 |
% |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• • – |
2024-06-11 |
4 |
S |
$53.03 |
$413,106 |
D/D |
(7,788) |
135,004 |
0 |
% |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• • – |
2022-09-08 |
4 |
AS |
$51.88 |
$1,115,420 |
D/D |
(21,500) |
168,346 |
0 |
% |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• • – |
2022-10-13 |
4 |
AS |
$47.28 |
$1,017,135 |
D/D |
(21,513) |
168,346 |
0 |
% |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• • – |
2023-02-16 |
4 |
D |
$44.13 |
$66,769 |
D/D |
(1,513) |
150,926 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• • – |
2023-02-09 |
4 |
AS |
$43.74 |
$306,180 |
D/D |
(7,000) |
156,589 |
0 |
% |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• • – |
2023-02-09 |
4 |
AS |
$43.73 |
$174,920 |
D/D |
(4,000) |
152,589 |
0 |
% |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• • – |
2022-07-14 |
4 |
AS |
$43.43 |
$933,745 |
D/D |
(21,500) |
168,346 |
0 |
% |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• – – |
2022-04-07 |
4 |
AS |
$42.58 |
$985,755 |
D/D |
(23,148) |
168,084 |
0 |
% |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• • – |
2022-06-09 |
4 |
AS |
$40.62 |
$873,330 |
D/D |
(21,500) |
168,346 |
0 |
% |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• • – |
2023-01-12 |
4 |
AS |
$40.47 |
$161,880 |
D/D |
(4,000) |
156,589 |
0 |
% |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• • – |
2023-05-03 |
4 |
AS |
$40.00 |
$280,000 |
D/D |
(7,000) |
167,183 |
0 |
% |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• • – |
2023-03-02 |
4 |
D |
$39.60 |
$427,086 |
D/D |
(10,785) |
140,141 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• – – |
2021-11-11 |
4 |
AS |
$39.56 |
$79,120 |
D/D |
(2,000) |
148,878 |
0 |
% |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• • – |
2023-05-11 |
4 |
AS |
$39.50 |
$70,587 |
D/D |
(1,787) |
165,396 |
0 |
% |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• • – |
2023-03-06 |
4 |
D |
$39.13 |
$194,007 |
D/D |
(4,958) |
135,183 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• • – |
2023-03-09 |
4 |
AS |
$39.10 |
$156,400 |
D/D |
(4,000) |
171,183 |
0 |
% |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• • – |
2023-06-08 |
4 |
AS |
$38.07 |
$95,175 |
D/D |
(2,500) |
163,164 |
0 |
% |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• • – |
2022-11-10 |
4 |
AS |
$38.04 |
$152,160 |
D/D |
(4,000) |
164,346 |
0 |
% |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
